Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Malaria Vaccines
Research from Royal Brisbane Hospital provides new data about malaria vaccines
February 25th, 2009
A new study, 'Effect of Plasmodium yoelii exposure on vaccination with the 19-kilodalton carboxyl terminus of merozoite surface protein 1 and vice versa and implications for the application of a human malaria vaccine,' is now available. According to a study from Brisbane, Australia, "It is well known that exposure to one antigen can modulate the immune responses that develop following exposure to closely related antigens. It is also known that the composition of the repertoire can be skewed to favor epitopes shared between a current infection and a preceding one, a phenomenon referred to as 'original antigenic sin.' It was of interest, therefore, to investigate the antibody response that...
Source: Vaccine Weekly (2009-02-25)
|
